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Abstract
Research in central nervous system (CNS) biology and pathology requires in vitro models, which, to recapitulate the CNS in vivo,
must have extensive myelin and synapse formation under serum-free (defined) conditions. However, finding such a model has
proven difficult. The technique described here produces dense cultures of myelinated axons, with abundant synapses and nodes of
Ranvier, that are suitable for both morphological and biochemical analysis. Cellular and molecular events were easily visualised using
conventional microscopy. Ultrastructurally, myelin sheaths were of the appropriate thickness relative to axonal diameter (G-ratio).
Production of myelinated axons in these cultures was consistent and repeatable, as shown by statistical analysis of multiple
experimental repeats. Myelinated axons were so abundant that from one litter of embryonic mice, myelin was produced in amounts
sufficient for bulk biochemical analysis. This culture method was assessed for its ability to generate an in vitro model of the CNS that
could be used for both neurobiological and neuropathological research. Myelin protein kinetics were investigated using a myelin
fraction isolated from the cultures. This fraction was found to be superior, quantitatively and qualitatively, to the fraction recovered
from standard cultures of dissociated oligodendrocytes, or from brain slices. The model was also used to investigate the roles of
specific molecules in the pathogenesis of inflammatory CNS diseases. Using the defined conditions offered by this culture system,
dose-specific, inhibitory effects of inflammatory cytokines on myelin formation were demonstrated, unequivocally. The method is
technically quick, easy and reliable, and should have wide application to CNS research.
Introduction
Research into biological and pathological mechanisms in the central
nervous system (CNS) requires both in vivo and in vitro models. For
in vitro models to be useful, they must accurately mimic the CNS
in vivo, with respect to both the types of cells present and their abundant
interactions. In the absence of such a model, many studies have to be
undertaken in vivo, with its attendant problems.
Currently, there are several types of tissue culture models of the
CNS: (i) organotypic (Bornstein, 1973; Bunge & Wood, 1973;
Seil, 1979; Billings-Gagliardi et al., 1980; Munoz-Garcia & Ludwin,
1986; Stanhope et al., 1986; Stoppini et al., 1991; Gahwiler
et al., 1991; Phelps et al., 1996; Dusart et al., 1997; Gahwiler et al.,
1997; Notterpek et al., 1993; Park et al., 2001; Ghoumari et al., 2003;
Birgbauer et al., 2004); (ii) aggregated cell cultures (Seeds & Vatter,
1971; Matthieu et al., 1978; Loughlin et al., 1997; Berglund et al.,
2004); and (iii) dissociated primary mixed (Yavin & Yavin, 1977;
Lubetzki et al., 1993; Svenningsen et al., 2003) or recombined
(Fitzner et al., 2006) cell cultures.
With respect to recapitulating the CNS in vitro, there are limitations
to the above methods. For organotypic cultures and aggregated
cultures, nutrient diffusion and gaseous exchange parameters impose
cell growth limitations. Additionally, it is not easy to visualise cellular
events by conventional light microscopy, due to sample thickness.
Dissociated cultures are technically simple, but may yield only patchy
myelination. Serum is a common additive to culture media for most
methods, but as the chemical composition of serum is not completely
deﬁned, its use adds an unknown variable to the experimental regime.
Because of the acknowledged difﬁculty in growing myelinated CNS
tissue, one long-standing method of generating myelinated CNS axons
has been by sourcing tissue from both the peripheral nervous
system and CNS and combining them in co-culture (Wood & Bunge,
1986). This style of culture does not accurately mimic the CNS in vitro.
We recently described an explant culture method of murine
embryonic spinal cord that yielded cultures thin enough for cellular
events to be visualised by standard light microscopy and growth of
myelinated ﬁbres ⁄ axons to be monitored and measured (Thomson
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et al., 2006). However, if axonal length is not of speciﬁc interest, then
having a technique that is technically quick and easy to establish, and
generates abundant myelinated axons and synapses, would be useful
for both neurobiological and pathological studies.
We have developed a tissue culture model derived purely from CNS
tissue, in which the cultures: (i) use media that is completely deﬁned
during myelin formation; (ii) have extensive myelin and synapse
formation; (iii) are suitable for viewing with conventional light
microscopy; and (iv) yield sufﬁcient material for bulk biochemical
analysis. To determine whether the technique generated a valid in vitro
model of the CNS, two studies were performed addressing mechanistic
questions in neurobiology and in neuropathology. These investigations
focused on the myelin component of the cultures, as the formation of
abundant myelin under deﬁned conditions is unique to this in vitroCNS
system. The model was used to investigate the kinetics of myelin
proteins, proteolipid protein (PLP–DM20) and myelin-associated
glycoprotein (MAG). The model was also used to dissect the molecular
pathogenesis of inﬂammatory CNS diseases such as multiple sclerosis,
by determining the effect onmyelin of cytokines such as tumour necrosis
factor-a (TNF-a), interleukin-1b (IL-1b), interleukin-6 (IL-6) and
interferon-c (IFN-c) (Woodroofe & Cuzner, 1993; Cannella & Raine,
1995; Navikas & Link, 1996; Lock et al., 2002).
This simple, robust method of culturing myelinated, synapsing CNS
tissue permits easy morphological examination and generates material
in quantities sufﬁcient for biochemical studies. With abundant
neurons, synapses, myelinated axons and nodes of Ranvier, this
culture method should facilitate developmental, structural and func-
tional studies in a wide variety of neuroscience areas.
Materials and method
A more detailed protocol is available on request and will contain any
updates and improvements to the method. For example, increasing
the poly(l-lysine) (PLL) concentration seems to increase cell
attachment.
Tissue source
Mice were bred and killed according to UK Home Ofﬁce standards.
Wild-type C3H101 female mice were time-mated and embryos were
collected on embryonic day (E) 13.5. The day of plugging was
denoted as E0.5; thus, if a mouse was plugged overnight on Monday
night (plug noted Tuesday morning), then the fetuses were used on the
Monday 13 days later. Fetuses at E12.5 and E14.5 were also trialled as
tissue sources. Body weight was used to monitor the pregnancy status
of the time-mated female mice. The time-mated females were weighed
on the day of plugging, and then every day from E10 onwards.
Between E10 and E13.5, the weight of a pregnant female mouse with
more than three fetuses would increase by 0.4–1.0 g ⁄ day. The average
litter size at parturition of C3H101 mice was seven (average of 100
litters). For dissociated oligodendroglial cultures, neonatal mice were
used on postnatal day (P) 5, where P1 was the day on which the litter
was ﬁrst observed.
Tissue culture ingredients
The concentrations of nutrients noted are the ﬁnal concentrations
in that solution. Cell culture media, such as Hank’s balanced salt
solution (HBSS) and Dulbecco’s modiﬁed Eagle’s medium (DMEM),
Leibovitz’s L15 medium, and horse serum, were obtained from Gibco
Invitrogen (Paisley, UK). Pig skin gelatin, Triton X-100, penicillin–
streptomycin, glucose, apo-transferrin, insulin, putrescine, sodium
selenite, progesterone, biotin, hydrocortisone, soybean trypsin
inhibitor, DNase and bovine serum albumin (BSA) fraction V were
obtained from Sigma (Poole, UK). Bovine albumin-Path-O-Cyte 4
was obtained from MP Biomedicals (OH, USA). Unless otherwise
speciﬁed, all DMEM contained 1000 mg ⁄ L glucose, 100 U ⁄mL
penicillin and 100 lg ⁄mL streptomycin.
Tissue culture media and reagents
Plating medium (PM). The medium used to encourage attachment of
spinal cord explants (Thomson et al., 2006) was used for plating the
dissociated spinal cord cells. This PM consisted of 50% DMEM, 25%
horse serum, 25% HBSS (with calcium and magnesium), and 2 mm
glutamine.
Differentiation medium (DfM). This formulation was the same as the
medium used to grow myelinating axons from spinal cord explants
(Thomson et al., 2006), and consisted of DMEM (4500 mg ⁄ L glucose),
0.5% hormone mix (see below), 10 ng ⁄mL biotin and 50 nm
hydrocortisone. In some experiments, DMEM-Advanced (Gibco)
was also trialled. Insulin (10 lg ⁄mL) was added to the DfM for the
ﬁrst 12–14 days of culture only, or for the full duration of culture.
Hormone mix. This formulation is based on the N2 mix (Bottenstein &
Sato, 1979), and consisted of 1 mg ⁄mL apo-transferrin, 20 mm
putrescine, 4 lm progesterone, and 6 lm selenium.
PLL. PLL (molecular weight 70 000–150 000; 13.3 lg ⁄mL) (Sigma)
was used to coat the coverslips (VWR International, Lutterworth, UK)
or 35-mm sterile Petri dishes (Nunclon; VWR International) as
previously described (Thomson et al., 2006). Three coverslips were
placed in each 35-mm Petri dish for morphological studies. For
biochemical studies, cells were plated directly onto the base of a PLL-
coated, 35-mm Petri dish.
Bottenstein–Sato medium (Sato medium). This medium was used for
primary oligodendrocyte cultures. It consisted of DMEM to which was
added Sato mix, giving a ﬁnal concentration of 2 mm glutamine,
100 lg ⁄mL apo-transferrin, 0.0286% bovine albumin-Path-O-Cyte
4, 0.2 lm progesterone, 100 lm putrescine, 0.45 lm thyroxine,
00.224 lm sodium selenite, and 0.5 lm tri-iodothyronine.
Co-culture medium. This medium was based on Sato medium but had
a higher level of glucose in the DMEM (4500 mg ⁄ L) and also
contained 50 nm hydrocortisone.
SD solution. Soybean trypsin inhibitor solution was used to stop
enzymatic activity during tissue dissociation. It consisted of
0.52 mg ⁄mL soybean trypsin inhibitor, 0.04 mg ⁄mL bovine pancreas
DNase and 3.0 mg ⁄mL BSA fraction V made up in Leibovitz’s L15
medium.
Culture methodology
All culture preparation and maintenance was performed in an aseptic
fashion using laminar ﬂow hoods, except for the tissue dissection
stage, which was performed on the bench. Cultures were maintained in
a 37C, humidiﬁed incubator under 5% CO2. Myelinating cultures
were fed three times weekly by replacing one-half of the medium;
oligodendrocytes were fed twice-weekly replacing three-quarters of
the medium each time.
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Myelinating mouse spinal cord culture
Myelinating spinal cord cultures were prepared by enzymatic and
mechanical dissociation of tissue from fetuses of time-mated mice. At
the appropriate stage of gestation, the pregnant mouse was killed with
an overdose of halothane and CO2, followed by cervical dislocation.
The gravid uterus was removed in an aseptic fashion into a sterile
plastic Petri dish, the fetuses were extruded and decapitated, and the
umbilical cord was cut. The point of decapitation was sited just caudal
to the attachment of the cerebellum, about 3 mm rostral to the cervical
ﬂexure. The inclusion of the caudal part of the myelencephalon with
the spinal cord in the cultures increased the amount of tissue from
which cells could be harvested. Thus, the myelencephalon extending
2–3 mm rostral to the cervical ﬂexure, and approximately 8–10 mm of
spinal cord caudal to the cervical ﬂexure, were removed from the fetus
into sterile DMEM (Fig. 1). The meninges were stripped as described
previously (Thomson et al., 2006), and the spinal cords were
transferred to the dry lid of the Petri dish, minced with a scalpel
blade, and then collected into a bijou containing 1 mL of HBSS
(calcium ⁄magnesium-free) for up to six spinal cords. To dissociate
more than six spinal cords, the dissociation volumes were scaled up
proportionately, e.g. nine spinal cords into 1.5 mL of medium. One
millilitre of 0.25% trypsin and 100 lL of 1.0% collagenase were
added per mL of HBSS, and the mixture was incubated at 37C for
20 min. One millilitre of SD solution was added per mL of HBSS, and
the tissue fragments were broken down by gentle trituration (four
times through a 21-gauge needle, and twice through a 23-gauge
needle). The cell suspension was placed in a conical centrifuge tube, to
which 5 mL of PM was added, and the cells were pelleted by
centrifugation at 90 g. The supernatant was discarded, and the cells
were resuspended in fresh PM at 0.4 mL per cord. Ten microlitres of
the cell suspension was added to 10 lL of 0.4% Trypan blue solution,
and the number of live cells was counted on a haemocytometer.
Additional PM was added to achieve a live cell count of 1500 ⁄ lL. For
morphological studies, 100 lL of the cell suspension (a total
of 150 000 cells) was plated on each 13-mm PLL-coated coverslip
in 35-mm Petri dishes (up to three coverslips per dish) and placed in
the tissue culture incubator for 2–3 h to allow the cells to attach. For
biochemical studies, 750 000 cells (500 lL) were seeded directly into
the centre of each PLL-coated 35-mm Petri dish. After the cells had
attached, they were fed. For coverslip cultures, the volume of PM was
made up to a total of 500 lL in the Petri dish, to which 500 lL of
DfM + insulin was added, ensuring that the coverslips were ﬁrmly
pressed down onto the base of the dish and fully submerged in the
medium. The total culture volume per dish was 1.0 mL. For cells
seeded onto Petri dishes for biochemical studies, a further 250 lL of
PM was added, making a total volume of PM of 750 lL per Petri dish.
To this was added 750 lL of DfM + insulin (total culture volume per
dish of 1.5 mL). The cultures were fed three times per week by
removing approximately half of the medium and adding sufﬁcient
fresh medium to bring the total volume up to 1.0 mL per Petri dish for
coverslips and 1.5 mL per dish for biochemical studies. The feeding
medium was DfM + insulin for the ﬁrst 12–13 days, and then DfM
without insulin for the remaining time, as prolonged exposure to
insulin had a negative effect (see Results). The serum used in
establishing the cultures declined to negligible levels by day 14, and
cultures were subsequently maintained in deﬁned medium. Cultures
were harvested at 4.5–5 weeks in vitro for biochemical studies, and at
various times for morphological studies.
Mouse forebrain cultures
Embryonic forebrains were also investigated as a potential tissue
source for myelinating cultures. They were harvested by splitting the
calvarium dorsally with forceps and scooping out the brain using a ﬁne
spatula. The cerebral hemispheres were separated from the thalamus
and the meninges were stripped. In E13.5 forebrains, the dorsal halves
of the hemispheres were relatively less developed and so it was
difﬁcult to strip the meninges from them; thus, only the ventral half of
the hemisphere was used. In E16.5 forebrains, the meninges were
readily removed and the whole hemisphere could be dissociated.
Dissociation and plating protocols were as for the spinal cords, but
with scaling up of the media and enzyme volumes as appropriate.
Mouse oligodendrocyte cultures
Dissociated cultures of murine oligodendrocytes were prepared as
described previously (Thomson et al., 1999). Brieﬂy, P5 mice were
killed by halothane overdose and decapitation. The spinal cords were
dissected and placed in DMEM, and the meninges were stripped. The
cords were transferred to the lid of a sterile Petri dish and minced with a
scalpel blade. The minced tissue was transferred to a bijou containing
HBSS without calcium or magnesium (three cords ⁄mL). To this was
added 0.25% trypsin (1 mL ⁄mL HBSS) and 1.0% collagenase
(100 lL ⁄mL HBSS). The suspension was incubated at 37C for
20 min, at which time a second pulse of trypsin and collagenase
was added. After a further 20 min of incubation, enzymatic activity
was terminated by adding 1 mL SD ⁄mL HBSS, the suspension was
triturated using a syringe and needle, and the cells collected by
centrifugation as for the embryonic spinal cords. The cells were
resuspended in DMEM ⁄ 10% fetal bovine serum (1 mL per cord) and
plated onto PLL-coated 13-mm glass coverslips (100 lL per coverslip)
in 24-well dishes or 35-mm plastic Petri dishes (500 lL per dish). The
cells were allowed to attach for 2 h in the incubator, and were fed with
0.5 mL per well or 1.5 mL per dish of Sato medium. Cells were
harvested at 7 days in vitro for morphological or biochemical studies.
Rat cultures
The above protocol for producing myelinated CNS cultures was also
trialled in rats, except that rat fetuses were used at E15.0–15.5, which
represents an equivalent stage of development to mouse E13.5 (http://
embryology.med.unsw.edu.au/OtherEmb/Mouse.htm).
Fig. 1. Dissection of the neuraxis from embryonic day 13.5 time-mated
mouse embryos. (A) Intact embryo removed from uterus. (B) Dissected
neuraxis left intact for orientation. FB, forebrain; M, myelencephalon; SC,
spinal cord. (C) Isolated myelencephalon–spinal cord as dissected during
culture preparation. The dotted lines indicate the portion of myelencephalon
and spinal cord used in the cultures. Ruler gradations are in millimetres.
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Spinal cord cells were dissociated and plated onto the coverslips in
DfM as for mouse cultures.
Cytokine treatment of cultures
The effects of cytokines, TNF-a, IL-6, IFN-c and IL-1b, on
myelination were studied. Cytokines were obtained from R&D
Systems, resuspended in DMEM with 0.1% BSA, and used at ﬁnal
concentrations of 5 and 20 ng ⁄mL for TNF-a, IL-6, and IL-1b. IFN-c
was added at 250 and 1000 U ⁄mL. Cultures were treated with
cytokines from day 15 to day 25 in vitro.
At the end of treatment, cultures were ﬁxed and immunostained for
myelin proteins PLP–DM20 and axons (phosphorylated neuroﬁla-
ment), and degree of myelination was evaluated as described below.
Morphological analysis
Immunostaining
The following antibodies (with their dilutions) were used: O10 against
extracellular epitope of proteolipid proteins PLP–DM20 (1 : 5) (Jung
et al., 1996); anti-myelin basic protein (MBP) (1 : 500; N. P. Groome,
Oxford, UK); AA3 against cytoplasmic and intramembranous PLP–
DM20 (1 : 10) (Yamamura et al., 1991) from S. Pfeiffer, University of
Connecticut, USA); SMI 31 against phosphorylated neuroﬁlament
(1 : 1500; Afﬁniti, Exeter, UK); neurofascin (1 : 1000; gift from
P. Brophy, UK); anti-caspr 1 (1 : 1000; gift from E. Peles, Israel); anti-
b-tubulin III (1 : 200; Sigma). Secondary antibodies were obtained
from Southern Biotech (Cambridge Bioscience, Cambridge, UK), and
included goat anti-(mouse IgM) (1 : 50); goat anti-(rat IgG)–ﬂuorescein
isothiocyanate (1 : 50); goat anti-(mouse IgG1)–Texas-red (1 : 80)
and goat anti-(mouse IgG2b) (1 : 40). Goat anti-(mouse IgG)–Cascade
Blue (1 : 80) was obtained from Molecular Probes (Leiden, the
Netherlands). All procedures were performed at room temperature
unless otherwise stated.
Immunostaining and electron microscopy (EM) techniques were as
previously described (Thomson et al., 2006). For surface labelling
with O10 antibody, live cells were rinsed brieﬂy in DMEM and the
primary antibody, diluted in DMEM, was applied for 30 min. The
coverslips were washed in DMEM for 1 min, and the secondary
antibody, diluted in DMEM, was applied for 30 min; coverslips were
washed in DMEM for 1 min, washed brieﬂy in phosphate-buffered
saline (PBS), and then ﬁxed in 4% paraformaldehyde ⁄ PBS for
15 min. After ﬁxation, to label cytoplasmic antigens, cultures were
washed in PBS three times for 20 min each, permeabilised with 0.5%
Triton X-100 in PBS for 30 min, and blocked using a blocking buffer
(0.2% pig skin gelatin, 0.1% Triton X-100 in PBS) for 30–60 min;
primary antibody, diluted in blocking buffer, was then added and left
on overnight at 4C. On the following day, the coverslips were washed
in PBS three times for 20 min each; the secondary antibody diluted in
blocking buffer was added for 1–2 h. The coverslips were washed in
PBS for 5 min, washed brieﬂy in distilled water, mounted in AF1
glycerol ⁄ PBS (Citiﬂuor, London, UK), and sealed using clear nail
varnish.
Plastic sections and ultrastructure
To obtain sections for EM, cultures were ﬁxed in strong ﬁxative
solution (2% paraformaldehyde ⁄ 5% glutaraldehyde in 0.08 m sodium
cacodylate buffer, pH 7.2), and the myelinated axons were harvested
as described previously (Thomson et al., 2006). Brieﬂy, a 3% solution
of agar (type VII, low gelling temperature; Sigma) was made up at
65C, and a drop was placed on the lid of a clean Petri dish and
allowed to gel. The culture material was removed as an intact sheet
from the coverslip by gentle scraping and ﬂushing with PBS while
being viewed under a dissecting microscope. The culture material was
balled up and placed on the drop of set agar, and a second drop of
liquid agar was placed on top and allowed to set. The agar–culture
sandwich was trimmed and left in strong ﬁxative solution until it could
be processed routinely for EM.
Light microscopy and photography
Light microscopy of the cultures was performed on an Olympus IX70
research ﬂuorescence microscope with standard epiﬂuorescence
optics. For EM, thin sections (70 nm) were evaluated on a JEOL
JEM-100CX II electron microscope. Images for analysis were digitally
captured.
Quantiﬁcation
Evaluation of myelination. Digital images were captured of non-
overlapping, consecutive microscope ﬁelds of the myelinated cultures.
The high density of myelinated axons made it too difﬁcult to count the
number ⁄ image. Consequently, a grid was superimposed on the images
and the number of myelinated axons (as represented by myelin
sheaths) crossing the grid lines was counted, summed and averaged.
The number of sheaths counted depended on the grid pattern used and
the resolution of the computer. To establish a baseline of the number of
myelinated axons produced by the culture method, 20–25 images per
coverslip, three coverslips for each sample, from 13 separate
experiments were counted (total 20–25 images · three cover-
slips · 13 experiments). For experiments in which the effects of
cytokines on myelination were examined, three coverslips per
condition were used and three experimental repeats were performed.
The data were expressed as percentage myelinated axons counted in
cytokine-treated samples relative to the non-treated control. To obtain
the baseline and cytokine trial data, the same grid and computer were
used, and all counts were performed by the same operator. For the data
associated with Fig. 3A, a different computer and grid were used,
counted by the same operator.
G-ratios. Thin sections (70 nm) and diffraction gratings were photo-
graphed at a magniﬁcation of 8000. G-ratios (axonal diameter to total
myelinated ﬁbre diameter) of 83 myelinated ﬁbres, from three different
cultures at 33 days in vitro, were calculated using Image-Pro Plus
4.0 software (Media Cybernetics, Silver Springs, MD, USA).
Statistical analysis
Underpinning the analysis of these results is the observation that the
trials were independent of each other and shared no common elements.
Counts of myelinated axons crossing lines of a superimposed grid
were performed to assess the number of myelin sheaths produced
under various culture conditions. All counts were performed by one
operator. To establish the reliability of this method for assessing the
number of myelin sheaths, images from the myelinating cultures were
selected at random and counted repeatedly over 1 week by the same
observer. That observer was blinded as to the results of previous
counts. The data were analysed, and the coefﬁcient of variation of the
mean of these readings was determined as being less than 0.040 (4%)
over this series.
To determine the yield of myelinated axons produced by the culture
method, the numbers of myelinated axons crossing superimposed grid
lines were counted for 13 experimental repeats (20+ images per
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coverslip, three coverslips per experiments, 13 experiments). The data
were analysed using standard statistical techniques to obtain the mean
and the standard deviation of myelin sheath counts. These data formed
the baseline dataset of normal myelin counts (referred to as ‘baseline-
13’) against which was compared the results of the cytokine trials. The
coefﬁcient of variation of the mean myelin sheath count was also
determined from these 13 experimental repeats.
Student’s t-test was used to compare data from control samples in
the cytokine trials with the baseline-13 dataset of normal values to
verify that the cytokine control sample results were consistent with the
expected value established by the baseline-13 dataset. If the data were
consistent, then the results from the cytokine trial replicates could be
compared with each other. In all cases, the null hypothesis, stating that
the mean myelin sheath count for each control sample in the cytokine
trials and the mean of baseline-13 dataset myelin counts were from the
same population, was accepted. This provided a solid basis for
combining the results of the cytokine trials and for comparison of the
results of cytokine repeat experiments with each other.
In assessing the effects of the cytokines on the development of
myelin sheaths in the cultures, the mean number of myelin sheaths for
each test sample was compared to the mean of the control sample
using Student’s t-test, Again, the null hypothesis (that the mean value
of each individual cytokine treatment would be no different from the
mean of control samples) was tested. The null hypothesis was rejected,
and an estimate of signiﬁcance of the difference is provided.
The effects of different cytokines, and cytokine doses, were also
compared with each other. In this case, the mean myelinated axon
counts were again compared using Student’s t-test, to examine the null
hypothesis that the effect of the cytokine (or its concentration) was
the same as that of a different cytokine or different concentration.
If the null hypothesis was rejected, an estimate of signiﬁcance of the
difference is provided.
In each case, the t-statistic determined was generated on the
assumption of unpaired, unequal sample sizes and the assumption that
the variances of the populations from which each of the samples were
taken were unequal.
Calculations were performed using a Corel Quattro Pro X3
spreadsheet (Corel Corporation, Ottawa, Canada; http://www.word
perfect.com and further analysed using GraphPad Prism v. 5.00 for
Windows (Graphpad Software, San Diego, CA, USA; http://
www.graphpad.com).
Biochemical analysis of myelinating co-cultures
Quantitative and qualitative analysis of myelin was performed on
myelinating cultures at 33 days in vitro. Extracts of myelin from these
cultures were compared to extracts of myelin-like membrane obtained
from primary dissociated oligodendrocytes cultured for 7 days. To
monitor growth in the myelinating and oligodendrocyte cultures,
parallel cultures were established simultaneously on coverslips (for
morphological evaluation by immunostaining) and in 35-mm Petri
dishes (for biochemical evaluation). A typical primary oligodendro-
cyte culture was prepared from ﬁve or six pups, which yielded
sufﬁcient material for six to eight Petri dishes. An average of between
ﬁve and seven embryos was obtained from each pregnant mouse,
which generated a sufﬁcient cell density for four to six Petri dishes per
preparation.
Cell radiolabelling
Myelin proteins were radiolabelled with [35S]methionine ⁄ cysteine
using a pulse-chase protocol that was developed for radiolabelling
primary dissociated oligodendrocytes (McLaughlin et al., 2006), with
the following modiﬁcations. Myelinating cultures or primary oligo-
dendrocyte cultures were incubated for 30 min in serum-free HBSS,
which was then replaced with HBSS containing 100 lCi per mL of
[35S]Promix (GE Healthcare Ltd) for 1 h. After this pulse period, the
35S-containing medium was removed, the dishes were rinsed with
HBSS, fresh culture medium was added, and the dishes were returned
to the incubator for an additional 18 h. After the chase period, the
dishes were rinsed twice in chilled PBS, snap frozen in liquid nitrogen,
and stored at )80C until required for biochemical analysis.
Myelin extraction
A lipid-rich fraction was extracted from myelinating cultures or
dissociated oligodendrocytes. A true myelin fraction can be isolated
from the myelinating cultures, whereas only a myelin-like fraction can
be isolated from dissociated oligodendrocyte cultures, as there are no
axons in these cultures about which myelin sheaths can form. For
simplicity, fractions from both types of culture will be referred to as
‘myelin fractions’.
The myelin fraction was extracted from the cultured cells using a
modiﬁed protocol for extracting myelin from CNS tissue (Yool et al.,
2001). Brieﬂy, 100 lL of chilled 50 mmHepes (pH 7.4), supplemented
with protease and phosphatase inhibitors, was added to each 35-mm
dish, the cellular material was scraped off the dish, and the resulting cell
lysate was syringed several times through a 26-gauge needle. A fraction
of the lysate was retained to represent the total homogenate, and the
remainder was mixed with 0.85 m sucrose solution in a total volume of
2 mL. The homogenates were transferred to a centrifuge tube, gently
overlayered with 1 mL of 0.25 m sucrose, and centrifuged at 75 000 g
for 1.5 h at 4C using a Beckman SW50.4 rotor. The lipid-rich, myelin
fraction was visible at the 0.85 ⁄ 0.25 m sucrose interface. It was
harvested and transferred to a 2-mL tube. The myelin fraction was
subjected to two rounds of hypotonic shock by the addition of ﬁve
volumes of chilled distilled H2O, and the myelin extract was pelleted by
centrifugation for 30 min at 13 000 g. The ﬁnal pellet was resuspended
in 50 mm Hepes supplemented with protease and phosphatase
inhibitors, and the protein concentrations of the total homogenate and
myelin fraction were determined using the BCA protein assay system
(Pierce Ltd, Perbio Science UK Ltd, Northampton, UK).
Immunoprecipitation and western blotting
Western blotting and immunoprecipitation procedures have been
described in detail previously (McLaughlin et al., 2002, 2006). The
amount of material used in each reaction was dependent on the
quantity of protein recovered in each fraction. Each immunoprecip-
itation reaction was conducted using a protein ratio of 20 : 1 for the
total homogenate ⁄myelin fraction, which typically equated to 50 lg
and 2.5 lg respectively. Western blot analysis was conducted using
20 lg and 1 lg of each fraction when available.
Results
Characterisation of cultures from embryonic mouse
spinal cord
After harvesting the dissociated cells by centrifugation, we found that
the optimal plating density was 150 000 (up to 200 000) cells in
100 lL of medium per 13-mm coverslip. Within 2 h of plating, the
cells had attached to the coverslip and were starting to extend short,
ﬁne processes. Within 24 h of plating, there was obvious process
development, and within the ﬁrst week, long processes had grown out
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from the cell bodies and were forming a dense reticulated pattern on
the coverslip.
Myelination began around day 15 in vitro on a few axons; however,
the major wave of myelination occurred between days 17 and 23
in vitro, after which time the extent of myelination increased with
respect to both numbers of axons and sheath thickness (Fig. 2).
The optimum time at which to study the myelinated cultures
morphologically was between 4.5 and 5 weeks. At this time, the
cultures were dense and axons had prominent myelination. After
5–6 weeks in culture, axons could start to deteriorate, although some
cultures remained viable and healthy for 9+ weeks.
Surface staining of living, myelinating cultures with O10 antibody
was attempted; however, only the top layer of myelin and cells was
immunolabelled (data not shown). Although these cultures were only a
few cell layers thick, the failure of antibodies to penetrate non-ﬁxed
and non-permeabilised cultures would suggest that a dense network of
ﬁbres and ⁄ or extracellular matrix develops.
Analysis of ﬁxed cultures immunostained for myelin antigens such
as PLP–DM20 or MBP (Figs 2, 4, 5 and 8) identiﬁed the production of
large numbers of myelinated axons, extending across the whole of
each culture. The extent of myelination made it difﬁcult to count the
number of sheaths per ﬁeld. Consequently, we devised a quicker
method to indicate the number of myelin sheaths per microscope ﬁeld.
This method also allowed us to evaluate the effect of factors that might
promote, or inhibit, myelin sheath formation. To establish a baseline
dataset, the numbers of myelinated axons crossing a superimposed
grid were counted on approximately 20 images obtained from each of
three coverslips for 13 different experimental repeats (therefore, the
baseline-13 dataset was derived from a total of 800 images). The
average number of myelinated axons crossing a set of grid
lines ⁄ image in the baseline-13 dataset was 21.05 ± standard deviation
4.43, with an SEM of 1.23 and a coefﬁcient of variation of 0.21. This
is a conservative reﬂection of the number of myelin sheaths in culture,
as sheaths that occur in a bundle ⁄ fascicle could not be counted, due to
Fig. 2. Myelination increases with time in culture. Co-labelled images stained for proteolipid protein (PLP)–DM20 (A, C, E and G) and axonal phosphorylated
neuroﬁlament (B, D, F and H) at 20 days (A and B), 23 days (C and D) and 26 (E and F) or 40 days (G and H) days in vitro. All time frames were harvested from the
same culture. Scale bar: 200 lm.
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superimposition. The number of myelin sheaths counted depends on
both the design of the superimposed grid and the resolution of the
computer. Figure 3A was generated on a computer with a different
resolution to the one on which the baseline-13 dataset and the cytokine
trials were analysed. Using the grid depicted in Fig. 3A, the number of
myelinated axons crossing the two concentric circles was re-counted
for six separate experiments. Counts were performed on a total of 12
contiguous, non-overlapping images from each of three coverslips (a
total of 36 images per experiment, six experimental repeats). The
number of sheaths crossing the grid ⁄ image as shown in Fig. 3A was
42.3 ± 10.24 (average plus standard deviation).
Ultrastructural evaluation of the myelin was performed on myeli-
nating cultures that had been harvested at 4–5 weeks in vitro. Myelin,
with well-developed periodicity, was readily observed surrounding the
axons (Fig. 3B–D). The average G-ratio for the cultured myelinated
ﬁbres was 0.76 ± 0.071 (average ± standard deviation).
Wild-type C3H101 mice were used throughout this study. Other
mouse strains were also used in preliminary investigations. Successful
cultures were obtained from the naturally occurring Mbp mutant,
Shiverer, and from the transgenic Plp-null mouse. In the Shiverer
cultures, many axons were lightly ensheathed, as indicated by positive
immunostaining for PLP–DM20 with appropriate negative immuno-
staining for MBP (data not shown).
Embryonic age was found to be a critical factor in obtaining
myelinating cultures. Spinal cord was harvested from E12.5, E13.5
and E14.5 embryos. The outcomes from each age were markedly
different, with E13.5 being adopted as the standard age of tissue
source. The average number of cells derived from one E13.5 spinal
cord was 1 200 000, which was sufﬁcient for approximately 8 ·
13-mm coverslips, each plated with 150 000 cells. These data were
derived from 106 cords harvested over 15 consecutive experiments.
Comparatively, the number of cells derived from E12.5 was approx-
imately 50% more, but myelination of axons during subsequent
culture was delayed by 4–5 days. Conversely, in cultures established
from E14.5 cords, the live cell yield after dissociation was markedly
reduced (approximately 50% less).
As for explant cultures (Thomson et al., 2006), cell survival and
myelination were markedly affected by the composition of the
Fig. 3. Myelin sheath formation in culture. (A) To indicate how much myelin forms in different experiments, a grid was superimposed on images and the number of
myelinated axons crossing each grid line was counted. This gives an indication of myelin sheath formation, not absolute numbers of sheaths formed. For comparison
between experiments, the same grid and computer settings must be used. Using the depicted grid, the average number of myelin sheaths per image was 42.3 ± 10.24
(average plus standard deviation, n = 216 images). (B and C) Electron micrographs depicting multiple myelinated axons indicated by asterisks (*) in transverse
section at 28 days in vitro. (D) Electron micrograph depicting the periodicity of the cultured myelin sheaths. Scale bars: A, 200 lm; B and C, 1 lm; D, 100 nm.
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medium. Hydrocortisone (Warringa et al., 1987; Kumar et al., 1989;
Chan et al., 1998) was added to all media as described previously
(Thomson et al., 2006). Similar to the situation observed in explant
culture (Table 1) (Thomson et al., 2006), insulin was found to be
helpful if present in the medium during the ﬁrst half of the culture
period, but if left in for the full duration of the culture, promoted
excessive numbers of oligodendroglia. These additional cells tended to
obscure the myelin sheaths. DMEM-Advanced was also trialled as a
base medium for the differentiation medium, but survival of both
neurones and oligodendrocytes was poor in this medium (compare
Fig. 4A and B with Fig. 4C and D). Co-culture medium resulted in
reasonable neuronal and axonal growth, but thin myelin sheaths with
intense staining of oligodendrocyte cell bodies (Fig. 4E and F). These
observations suggest reduced translocation of the myelin protein
isoforms, PLP–DM20, to the sheath. Previously, we have tested
neurobasal medium with B27 supplement on spinal cord explants, but
it did not support obvious myelin formation (Thomson et al., 2006),
and so was not tested in the dissociated cultures.
Nodes of Ranvier and sequential internodes developed along the
axons in these cultures. Using myelin-speciﬁc stains (PLP–DM20 or
MBP), the nodes could be seen as small breaks in the myelin sheath
(Fig. 5A, B and D, large arrows); heminodes were also detected (small
arrows). The molecules expressed in the nodal region of these cultured
ﬁbres mimicked those observed in vivo. Speciﬁcally, both caspr and
neurofascin were clustered around the nodes (Fig. 5C and E).
Synaptophysin antigens were abundant around nerve cell bodies
and along the length of neuronal processes, (Fig. 6A and B); however,
synaptophysin staining was not observed in the myelinated regions of
axons (Fig. 6C–E). Synapses were also readily identiﬁed by EM
(Fig. 6F and G).
Results of using other tissue sources for cultures
As the forebrain has a larger tissue volume, it was also trialled as a
tissue source for myelinating cultures. Tissue from both E13.5 and
E16.5 mouse fetuses was tried; the latter was selected, as development
of the forebrain occurs at a later embryonic time point than that of the
spinal cord. Cell survival of the dissociation procedure was good, but
cells degenerated during the culture period, such that by 3 weeks,
Fig. 4. Culture integrity was determined by media composition. Myelinating cultures were grown in different media and harvested at 32 days in vitro, ﬁxed and
immunostained for proteolipid protein (PLP)–DM20 (A, C and E) and axonal phosphorylated neuroﬁlament (B, D and F). (A and B) Cultures grown in standard
differentiation medium. (C and D) Cultures grown in differentiation medium using DMEM-Advanced (Gibco) as a basal medium. (E and F) Cultures grown in
co-culture medium. Scale bars: 200 lm. Arrowheads indicate cell bodies.
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there were few surviving axons ⁄ neurons and no myelin, using either
deﬁned medium or co-culture medium (data not shown).
Rat embryonic spinal cord was also trialled as a source of tissue for
myelinating cultures. Although the initial survival of cells in cultures
derived from embryonic rat spinal cord was good, by 2 weeks in vitro,
cell death was obvious, and by 3 weeks, survival of neurons and
olidogendroglia was poor; consequently, formation of myelin was
scarce (Fig. 7A and B).
Effects of cytokines on myelination
To ascertain whether this method of generating myelinated cultures
creates a valid model of the CNS for evaluating neuropathological
conditions, the results of adding pro-inﬂammatory cytokines to
myelinated axons were studied. Four different cytokines, each at
two different concentrations, were added to the myelinating cultures,
and the effects were determined by counting the number of myelinated
axons crossing a superimposed grid. An example of the impact of a
pro-inﬂammatory cytokine (IFN-c) on myelination is compared with
the non-treated controls in Fig. 7C and D. Cytokine experiments were
performed in triplicate; thus, the total number of images in which
myelinated axons were counted was between 160 and 180 for each
experimental condition. The actual number of myelinated axons
crossing the grid in the control (non-treated) cultures for the three
experimental repeats was 18.2 ± 1.45 (average ± SEM), with a
coefﬁcient of variation of 7.97%. These data for the controls were
consistent with the data derived in the baseline-13 dataset. The data
comparing the effects of adding the cytokines to the cultures were
expressed as percentage change of the control cultures in each
experiment. The data from the three experimental repeats are
presented in Fig. 7E. The combined results of the three experimental
Fig. 5. Numerous nodes of Ranvier form in myelinating cultures. Cultures were stained at 34 days in vitro for myelin basic protein (MBP) (A) or proteolipid protein
(PLP)–DM20 (B and D) and co-stained for neurofascin (C) or caspr (E). Large arrows in A indicate nodes of Ranvier; small arrows indicate heminodes. Similar-
shaped arrows indicate nodes of Ranvier and neurofascin in the perindodal area (B and C) or nodes of Ranvier and caspr in the paranodes (D and E). Scale bars: A,
25 lm; B, 20 lm; E, 10 lm.
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repeats show that the addition of each cytokine, at either dose, had an
unequivocal, negative effect on myelination when compared to the
control (non-treated) culture (P = 0.0001). Profound inhibition of
myelination occurred with IL-1b 20 ng ⁄mL, TNF-a 20 ng ⁄mL, and
IFN-c at either dose (P  0). Three cytokines (TNF-a, IFN-c and
IL-1b) exhibited obvious dose–response curves; the effect of IL-6 is
less clear, and requires further examination. The effects of the
cytokines, at the different concentrations, were also compared to each
other (Table 1). Some cytokines were found to have similar effects on
myelination (e.g. TNF-a at 20 ng ⁄mL and IFN-c at 250 U ⁄mL, not
signiﬁcantly different), whereas cytokines such as TNF-a at
20 ng ⁄mL and IL-1b at 20 ng ⁄mL had effects on myelination that
were extremely signiﬁcantly different (P < 0.0001) from each other
(Fig. 7E, Table 1).
Biochemical studies of myelin protein kinetics
A central objective of this study was to ascertain whether this system
can generate material sufﬁcient for detailed biochemical analysis of
myelin protein production and the integration of such proteins into the
myelin sheath. First, the total amount of protein recovered from the
myelin fraction was determined. As myelin is a repository for key
protein components, including MAG and PLP–DM20 (Grifﬁths et al.,
1998; Baumann & Pham-Dinh, 2001), the steady-state levels of these
proteins were measured in the myelin fraction and total homogenate to
assess their level of enrichment in the myelin fraction. The data were
compared to data obtained from cultures of primary oligodendrocytes,
in which cells develop extended myelin-like membranes in the
absence of axonal contact (Benjamins & Nedelkoska, 1994).
Cell cultures (myelinating and oligodendrocyte) were established in
Petri dishes and on coverslips to permit both biochemical and
morphological analysis of each cell culture system. Myelinating
cultures were harvested at 33 days in vitro for biochemistry and
morphological evaluation (Fig. 8A and B). Dissociated oligodendro-
cytes were harvested at 7 days in vitro, by which time the
oligodendrocytes had extended large myelin-like membranous sheets
(Fig. 8C and D).
A signiﬁcantly higher protein yield was obtained from myelin
isolated from the myelinating cultures (28.9 ± 2.2 lg per experiment)
as compared to the oligodendrocyte culture system (6.7 ± 0.9 lg per
experiment) (Fig. 9A). These protein yields were averaged from three
separate preparations, using ﬁve to seven embryos for myelinating
cultures and ﬁve or six pups for oligodendrocyte cultures. The protein
yield obtained from the myelin fraction represents 2.3% ± 0.23%
(myelinating cultures) and 0.93% ± 0.1% (oligodendrocyte cultures)
of the total cellular protein that was pool harvested (Fig. 9B). This
amount of material was sufﬁcient for protein analysis by western
blotting and also for isolation by immunoprecipitation. A comparison
between the myelin yields relative to total cellular protein obtained
between these two systems should be interpreted judiciously, as the
total cellular protein from the myelinating cultures contains protein
from other glia, neurons and axons, as indicated by the prominent
staining for phosphorylated neuroﬁlament in Fig. 9C. Conversely, the
oligodendrocyte cultures are neuron-free and, at 7 days in vitro, have
little contamination from other glia. Therefore, if the myelin yield
could be compared to total cellular protein just derived from
oligodendroglia, the yield would be proportionately much greater
from the myelinating cultures than from the dissociated oligodendro-
cyte cultures. It is worth noting that we routinely obtain
0.38 ± 0.02 mg of protein from the myelin fraction isolated from
the spinal cord of a normal P20 mouse. Such cords have a total protein
content of approximately 11.4 ± 0.6 mg (where n = 3 ± SEM). The
myelin protein yield from a P20 cord is calculated to be 3.3% of the
total homogenate, which is in a similar range to the myelin protein
yield obtained from the myelinating cultures.
Table 1. Comparison between mean values of myelin sheath counts after adding different cytokines or cytokine doses, utilising combined results from three
experimental repeats
IL-6, 5 ng ⁄mL
(n = 163)
IL-6, 20 ng ⁄mL
(n = 172)
TNF-a, 5 ng ⁄mL
(n = 179)
TNF-a, 20 ng ⁄mL
(n = 177)
IL-1 b, 5 ng ⁄mL
(n = 180)
IL-1 b, 20 ng ⁄mL
(n = 180)
IFN-c, 250 U ⁄mL
(n = 178)
IL-6, 20 ng ⁄mL (n = 172)
t-Value 0.267
P-Value 0.789NS
TNF-a 5 ng ⁄mL (n = 179)
t-Values 0.237 0.533
P-Values 0.813NS 0.594NS
TNF-a 20 ng ⁄mL (n = 177)
t-Values 12.295 11.735 14.657
P-Values < 0.0001** < 0.0001** < 0.0001**
IL-1 b 5 ng ⁄mL (n = 180)
t-Values 1.429 1.138 1.858 11.391
P-Values 0.154NS 0.256NS 0.064* < 0.0001**
IL-1 b 20 ng ⁄mL (n = 180)
t-Values 4.956 4.606 5.916 8.299 3.655
P-Values < 0.0001** < 0.0001** < 0.0001** <0.0001** < 0.0003**
IFN-c 250 U ⁄mL (n = 178)
t-Values 11.222 11.686 13.390 1.606 10.235 6.981
P-Values < 0.0001** < 0.0001** < 0.0001** 0.109NS < 0.0001** < 0.0001**
IFN-c 1000 ng ⁄mL (n = 176)
t-Values 18.594 17.704 22.692 8.986 18.092 16.015 16.015
P-Values < 0.0001** < 0.0001** < 0.0001** < 0.0001** < 0.0001** < 0.0001** < 0.0001**
IL-6, interleukin-6; TNF-a, tumour necrosis factor-a; IL-1b, interleukin-1b; IFN-c, interferon-c; NSnot signiﬁcant; *not quite signiﬁcant; **extremely signiﬁcant.
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Western blotting was used to determine the steady-state levels of
PLP–DM20 and MAG in the myelin fractions obtained from both
culture systems (Fig. 9C). As described in Materials and methods, a
ratio of 20 : 1 total homogenate to myelin fraction had to be used to
generate a signal intensity that was similar, and hence quantiﬁable, in
each fraction. PLP and DM20 were found to be enriched in both
cultures, with PLP being 64 ± 11-fold enriched in myelinating
cultures and 40 ± 12-fold enriched in oligodendrocytes (Fig. 9D).
MAG, on the other hand, was enriched 13.3 ± 2.2-fold in myelinating
cultures and by a signiﬁcantly lower factor of 5.0 ± 1-fold in myelin-
like fraction from oligodendrocytes.
To determine whether this culture technique provides a valid model
of the CNS in vitro, the neurobiology of myelin protein kinetics was
studied. The incorporation efﬁciency of PLP–DM20 into the myelin
fraction in both cell culture systems was investigated using 35S
radiolabelling of nascent proteins. Fig. 9E depicts nascent PLP–DM20
that was immunoprecipitated from total cell homogenate or myelin
extracts of both culture systems. Loading the gels at the 20 : 1 ratio
described above generated robust signals from PLP and DM20 in both
the total homogenate and myelin fraction. These signals derived from
20 : 1 loading ratios were quantiﬁed, and their intensity in the myelin
fraction was expressed relative to the total fraction (Fig. 9F). There
was no signiﬁcant difference between the myelinating culture and the
oligodendrocyte culture in the incorporation efﬁciency of either PLP
(73% ± 16% and 65.1% ± 9.5%, respectively) or DM20
(72.7% ± 15% and 51.5% ± 8.8%). These values are similar to the
incorporation efﬁciency of nascent PLP into the myelin fraction of
brain slices of wild-type mice maintained in an artiﬁcial cerebrospinal
ﬂuid medium for up to 6 h (McLaughlin et al., 2007).
Discussion
For in vitro models of the CNS to be representative, they must
accurately mimic the CNS in vivo, with respect to cell types and
cellular interactions. Most biological or pathological studies on CNS
myelin rely on in vivo experimentation, because in vitro methods have
not reliably produced myelin in sufﬁcient amounts for biochemical
Fig. 6. Abundant synapses form in the myelinating cultures. Cultures were co-stained at 30 days in vitro for neurons (A) or synaptophysin (B). The same neurons in
A and B are indicated by an asterisk and a star. In C, D and E, the same region of the culture is immunostained for synaptophysin (C) and myelin sheaths (D) or
co-labelled on the same image (E). Synaptophysin was abundantly expressed in a punctuate pattern around nerve cell bodies (A) and naked axons (C and E), but not
in regions of myelin sheath formation (D and E). Cultures were also examined ultrastructurally for synapse formation (F and G); arrows indicate synapses. (A)
b-Tubulin. (B and C) Synaptophysin. (D) Proteolipid protein (PLP)–DM20. (E) Synaptophysin and PLP-DM20. Scale bars: A and C, 10 lm; F, 250 nm.
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EFig. 7. Illustration of results obtained from studies using rat embryonic tissue as a source for myelinating cultures (A and B) and the effect of certain cytokines on
myelin formation in mouse cultures (C–E). (A and B) Cultures derived from rat embryo tissue at a cognate age of gestation to embryonic day 13.5 mouse embryos
had poor cell survival, low axonal density and myelin sheath formation at 21 days in vitro. The same culture co-labelled for proteolipid protein (PLP)–DM20 (A) and
phosphorylated neuroﬁlament (B). Scale bar: 200 lm. To assess whether the cultures were a valid model for in vitro studies on the central nervous system,
pro-inﬂammatory cytokines were added to the cultures and their effects on the formation of myelinated axons were determined at 24 days in vitro. (C) Control
(non-treated) myelinating culture. (D) Culture treated with interferon-c (IFN-c) 1000 U ⁄mL for 10 days during the period of active myelination. The arrow indicates
a rare myelinated ﬁbre developing in IFN-c-treated culture; arrowheads indicate oligodendroglial cell bodies. Scale bar: 100 lm. (E) Graph depicting the effect of
adding different cytokines to myelinating cultures. Results of individual trials and the combined results are shown. Units on the horizontal axis: interleukin-6 (IL-6),
interleukin-1b (IL-1b) and tumour necrosis factor-a (TNF-a), ng ⁄mL; IFN-c, U ⁄mL.
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analysis. Our aim was to develop a method of culturing mammalian
CNS tissue that is a close representation of the CNS in vivo. Our
general speciﬁcations for the culture were for it to generate abundant
myelinated axons and synapses, be technically easy, robust, and
reproducible, have deﬁned culture conditions, and facilitate visuali-
sation of cellular events. Speciﬁcally, we wanted cultures that
generated myelin in quantities sufﬁcient for bulk biochemical
analytical techniques. The method that we present here appears to
fulﬁl all of these criteria. The morphological and biochemical data
obtained from these cultures support the concept that this method
recapitulates the CNS in vitro, and could be used to research biological
and pathological mechanisms.
Tissue source and culture media composition is critical
We examined the inﬂuences of embryonic age and media composition,
with the aim of identifying the best myelinating conditions. For the
cultures described in this article, E13.5 mice were the optimum tissue
source. Tissue from younger embryos (E12.5) also yielded myelinating
cultures, but a longer culture period was required, whereas tissue from
E14.5 embryos had a greatly reduced cell yield. However, when rat
embryos at a cognate stage to mouse development were used, survival
of neurons was poor. In collaborative studies with A. Sorenson and
S.C. Barnett (Glasgow), we have established a different method for
producing myelinating rat spinal cord cultures, by culturing them on a
monolayer of astrocytes (Sorensen et al., 2008).
The composition of the medium is the other absolute determinant of
culture success, as also shown in our previous study on spinal cord
explants (Thomson et al., 2006). The medium used here is relatively
simple, has no growth factors per se, although it does have insulin, and
has declining levels of serum for the ﬁrst 12–13 days. Subsequently,
the medium is insulin-free and completely deﬁned (serum-free) during
the critical period of myelin sheath formation, which begins around
day 15 in vitro. This is the same medium that resulted in the best
myelination and axonal growth in the explant cultures (Thomson
et al., 2006).
Intercellular interactions are similar to those in in vivo systems
Myelination begins in the cultures at around 15–16 days, and is
extensive by 22–28 days. Cultures can remain viable beyond
2 months. Myelin formation is widespread and of a comparable
thickness to that obtained in vivo. The G-ratio, a measure of myelin
sheath thickness relative to axonal diameter, of the myelin sheaths
produced in our cultures was 0.76 ± 0.071 at 17–19 days after the
onset of myelination. This value is comparable to measurements
Fig. 8. Examples of cultures used for biochemical preparations. Biochemical preparations were obtained from myelinating cultures derived from embryonic mice
and grown for 33 days (A and B) and from dissociated neonatal mouse spinal cord oligodendrocytes, cultured for 7 days (C and D). Myelinating cultures were co-
labelled for proteolipid protein (PLP)–DM20 (A) and phosphorylated neuroﬁlament (B). Mouse oligodendroglia were co-stained for cell surface PLP–DM20 using
the O10 antibody on live cells (C), and for cytosolic PLP–DM20 using AA3 antibody (D) after ﬁxation and permeabilisation of cells. Scale bars: A and B, 200 lm;
C, 50 lm.
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obtained from small-diameter axons in the optic nerve and large-
diameter ﬁbres from the ventral funiculus of the spinal cord of P20
mice (0.78 ± 0.06 and 0.711 ± 0.01, respectively) (I. R. Grifﬁths, J. E.
Edgar, unpublished results).
Data established from 13 experimental repeats (number of images
assessed 800) indicate consistent, reliable production of myelin-
ated axons, across the whole of the culture area and between
cultures.
Nodes of Ranvier are essential for rapid, saltatory conduction in the
nervous system. As a consequence of becoming myelinated, the nodal,
paranodal and juxtaparanodal domains of the axon are precisely
organised at the molecular level to create the structural and functional
properties of the nodes (Vabnick & Shrager, 1998). Nodes were
identiﬁed frequently in the myelinating culture and had appropriate
molecular specialisations of caspr and neurofascin. Caspr 1 (contactin-
associated protein) is a major transmembrane component of the axo-
glial junction at the paranode in both the peripheral nervous system
and CNS, and may have a role in reciprocal signalling between the
two cell types (Einheber et al., 1997; Peles & Salzer, 2000). Its
expression at the paranodes on either side of the node gives it the
characteristic, doubled appearance indicative of well-formed perinodal
domains. Neurofascins, expressed by neurons and glia, are also
involved in axo-glial adhesion at the paranode (NF155) and in the
structural specialisations of the adjacent node (NF186) (Tait et al.,
2000; Sherman et al., 2005). The antibody that we used detects both
neurofascins, so single domains of positive staining in the
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Fig. 9. Myelin-enriched fraction can be isolated from myelinating cultures and used for myelin protein kinetic studies. (A) The data shown indicate the average
protein yield (28.9 ± 2.2 lg) of the myelin fraction obtained from three experimental repeats for myelinating cultures (MC) as compared with the yield
(6.7 ± 0.9 lg) from the myelin-like fraction isolated from oligodendrocyte cultures (OC). Each preparation was from one litter of ﬁve to seven embryos or ﬁve or six
pups. Each tissue source yielded sufﬁcient material to generate 6 · 35-mm2 Petri dish cultures. (B) The average protein recovered from the myelin fraction for each
preparation is expressed relative to the total protein content of the homogenate. (C) Representative examples of western blot analysis of the two myelin proteins
proteolipid protein (PLP)–DM20 and myelin-associated glycoprotein (MAG) detected in the total homogenate and myelin fraction from each culture type. The total
homogenate (T) and the myelin fractions (M) were loaded onto the gel at a ratio of 20 : 1 (typically 20 lg and 1 lg respectively). Western blot staining for neuronal
proteins (phosphorylated neuroﬁlament) showed that there was no detectable contamination of the myelin fraction harvested from the myelinating cultures. It also
showed that a signiﬁcant proportion of the protein in the total cell homogenate of myelinating cultures is neuronally derived. The blots were stripped and reprobed
with b-actin to assess equivalence of loading. (D) The intensity of the protein in the myelin fraction was corrected for the amount loaded onto the gel and expressed
as the fold enrichment relative to the total homogenate intensity. (E) Nascent PLP and DM20 isoforms were incorporated into the myelin fraction. Representative
phosphorimages of nascent PLP and DM20 immunoprecipitated from the myelin fraction and total homogenate are shown for each culture type. The nitrocellulose
membranes were analysed by western blotting to compare the levels of PLP and DM20 isoforms recovered from each fraction. (F) The western blots were then
quantitatively analysed by assessing the intensity of the signal for nascent PLP and DM20 isoforms relative to the total cellular homogenate. Note that the
quantiﬁcation is of the actual signal intensities in these blots, which were derived from loading 20 times more total cell homogenate then myelin fraction. Thus, if this
20-fold factor is taken into account, the absolute yield of PLP and DM20 in the myelin fraction is much higher than in the total cell homogenate.
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nodal ⁄ paranodal region were identiﬁed. The combined data consisting
of the obvious interruptions in the myelin sheath (stained for PLP–
DM20 or MBP) and the robust staining of the node ⁄ paranodal
molecules caspr and neurofascin attest to an abundance of well-
developed myelin sheaths in these myelinating cultures.
Synapse formation was extensive throughout the cultures, as
indicated by synaptophysin expression and EM. Synaptophysin is a
38-kDa protein of the presynaptic vesicles of the CNS and neuromus-
cular junctions, and is a marker of synapse formation (Jahn et al., 1985;
Wiedenmann & Franke, 1985; Navone et al., 1986; Calakos & Scheller,
1994; Berglund et al., 2004). Synaptophysin expression occurred in
these cultures where synapse formation would be expected, i.e. over
neuronal cell bodies and processes, but not over myelin sheaths.
Myelin can be extracted in sufficient quantities for biochemical
investigations
The culture method described here produces myelin in sufﬁcient
quantities to permit its speciﬁc extraction and the subsequent analysis
of key myelin components. We compared the data (total myelin
recovery, myelin protein steady-state levels and enrichment of PLP–
DM20 and MAG in the myelin fraction) from the myelinating cultures
with that obtained from primary dissociated oligodendrocytes. This
comparison provides an insight into the quality of the material
extracted from the myelinating culture. There is a signiﬁcantly greater
yield of myelin fraction from the cultures in which true myelin sheath
is formed than from the primary oligodendrocyte cultures in which just
a myelin-like membrane is formed. This difference reﬂects the high
density of compact myelin that forms in the myelinating culture as
compared with the diffuse myelin-like, membranous sheets of the
dissociated oligodendrocytes. The proportion of protein recovered in
the myelin fraction relative to the total protein content from the
myelinating culture (2.3%) was similar to that recovered from
homogenised spinal cord tissue harvested from a P20 mouse (3.3%).
Conversely, the proportion recovered from the myelin-like fraction of
the oligodendrocyte cultures, in which all proteins are glial-derived
(non-neuronal), was signiﬁcantly less (0.93%). These data are
consistent with the formation of adequate myelin, as indicated by
the G-ratio data.
The myelin extraction protocol used in this study, and in many other
laboratories, utilises differential centrifugal separation to isolate the
lipid-rich myelin. Although the resulting myelin fraction is enriched in
myelin lipids and proteins, it may also contain contaminants from the
non-myelin fraction, including axolemmal components (Menon et al.,
2003). To conﬁrm that the myelin fraction was enriched in myelin
components, we analysed proteins associated with compact myelin
(PLP–DM20), non-compact myelin (MAG) and axonal components.
Both PLP and DM20, and to a lesser extent MAG, were greatly
enhanced in the myelin fraction, and axonal contamination was not
detected in this fraction. The greater abundance of PLP–DM20, as
compared with MAG, in the myelin fraction is consistent with in vivo
expression of these proteins in myelin. PLP–DM20 accounts for 50%
of total myelin proteins in the CNS, whereas MAG comprises only 1%
E
F
Fig. 9. Continued.
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(Baumann & Pham-Dinh, 2001). A similar enrichment of PLP–DM20
was observed in the myelin-like fraction obtained from the oligoden-
drocytes.
Validation of the cultures as in vitro models of the CNS for
neurobiological and neuropathological research
Fundamental biological studies on myelin involve determining the
kinetics of myelin protein production and incorporation of such
proteins into the myelin sheath. The pathogenesis of dysmyelinating
diseases can involve failure of transport and incorporation of key
myelin proteins such as PLP–DM20 into myelin (McLaughlin et al.,
2006). The rumpshaker mouse has a dysmyelinating phenotype
associated with Plp1 mutation (Ile186Thr) (Schneider et al., 1992)
and serves as a model for human dysmyelinating disorders such as
Pelizaeus–Merzbacher disease. Using an in vitro brain slice system,
we have demonstrated previously that the incorporation of PLP–
DM20 into myelin of rumpshaker mice is compromised as compared
to wild-type mice (McLaughlin et al., 2006). Kinetic studies on myelin
proteins in brain slices use the myelin–axon units established in the
living animal are hence valid representations of the in vivo situation.
However, technical difﬁculties have limited such studies on myelin
protein kinetics, as brain slices are only viable for a restricted time
period, which we estimate to be up to 7 h. Using myelinating cultures
prepared by the technique described in this article, we can now study
myelin protein kinetics for unrestricted times, under deﬁned condi-
tions. A robust signal for radiolabelled nascent PLP–DM20 was
detected in the myelin fractions isolated from both the myelinating and
dissociated culture systems. The yield of labelled protein ⁄ culture was
much greater from the myelinating cultures than from the oligoden-
drocyte cultures, permitting more extensive kinetic studies of myelin
protein assembly and stability. Qualitative differences exist between
compact myelin and myelin-like membranes, including differences in
myelin proteins and lipids and the organisation of the membrane into
lipid rafts (Marta et al., 2003; Fitzner et al., 2006). Consequently, the
myelin-like membranes obtained from dissociated oligodendrocytes
do not appear to be accurate biochemical representations of compact
myelin. However, comparison of the data from the myelinating
cultures with those from brain slices supports the hypothesis that the
myelinating cultures generated by this technique are a valid represen-
tation of the CNS in vitro and can be used to study myelin protein
kinetics. We are now using the myelinating cultures to dissect the
mechanisms controlling myelin formation and maintenance in normal
myelin and developmental disease conditions, such as in the
dysmyelinating mouse mutant, rumpshaker.
An inﬂammatory response involving microglia, macrophage acti-
vation and T-cell invasion is a central feature of both developmental
and acquired, myelin-related disorders such as Pelizaeus–Merzbacher
disease and multiple sclerosis. The inﬂammatory response may
precipitate myelin abnormalities (Ip et al., 2006) or, conversely, it
may promote remyelination (Setzu et al., 2006). Teasing out the roles
of individual events or speciﬁc molecules in vivo is challenging, due to
individual animal variability. A major advantage of the technique
described in this article is that the chemically deﬁned conditions used
during myelination enable precise examination of the impact of
speciﬁc molecules, such as cytokines, on myelination. The method of
assessment is robust and produces results that are highly statistically
signiﬁcant.
The roles of cytokines, such as IFN-c, TNF-a, IL-1b and IL-6,
expressed in inﬂammatory diseases such as multiple sclerosis are
complex (Merrill & Benveniste, 1996; Sharief, 1998; Minagar &
Alexander, 2003; Imitola et al., 2005). They may be a direct, or
indirect, cause of glial and myelin loss or axonal damage (Li et al.,
1993; Brosnan et al., 1995; Parkinson et al., 1997; McManus et al.,
1998; Sharief, 1998; Hesselgesser & Horuk, 1999; Huang et al., 1999;
Adorini, 2004; Imitola et al., 2005; Zaheer et al., 2007). We found that
their addition to the cultures had highly signiﬁcant, cytokine-speciﬁc
and dose-dependent negative effects on myelin sheath formation,
validating the use of this method of cell culture as a model for
dissecting the molecular pathogenesis of CNS diseases. The data
provided by these cytokine trials establish a model for investigating
the effects of cytokines on myelin sheath formation as seen during
developmental disorders, or during demyelinating diseases. Further
studies would include adding lower doses of these cytokines, and ⁄ or
combinations of cytokines, for a longer period during myelin
formation. To investigate the role of cytokines in demyelinating
diseases, cytokines could be added to the cultures after myelination
has occurred (> 5 weeks in vitro.) Using this model, the speciﬁc
effects of other molecules that are known to inﬂuence normal
myelination, such as transferrin (Garcia et al., 2004; Sow et al., 2006),
could be examined in more speciﬁc detail.
The technique described in this article for growing myelinating,
synapsing CNS tissue in vitro is simple, deﬁned, and robust. It permits
easy morphological and biochemical analyses of cellular events
associated with intercellular connections and myelination. This
method of culturing CNS tissue should overcome many of the
limitations of other CNS culture techniques, and advance research in
areas of developmental neurobiology and CNS diseases, especially
those involving myelin.
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